Roger S McIntyre, MD, FRCPC

Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. Dr. McIntyre is also director for the Depression and Bipolar Support Alliance (DBSA) from Chicago, Illinois, USA.
 
Dr. McIntyre was named by Clarivate Analytics/Thomson Reuters in 2014, 2015, 2016, and 2017 as one of “The World’s Most Influential Scientific Minds”. This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade. 
 
Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity.  His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment. 
 
Dr. McIntyre is extensively involved in medical education.  He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.
 
Dr. McIntyre is a contributor to the Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder and Bipolar Disorder. Dr. McIntyre was the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders. Dr. McIntyre has published more than 400 articles/manuscripts and has edited and/or co-edited several textbooks on mood disorders. 
 
Dr. McIntyre completed his medical degree at Dalhousie University.  He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.
Dr. McIntyre is involved in multiple research endeavours which aim to characterize the association between mood disorders, especially cognitive function and medical comorbidity.  Broadly, his work aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.
Pharmacol Rep. 2018 Jul 21;70(6):1173-1179
Menezes CES, McIntyre RS, Chaves Filho AJM, Vasconcelos SMM, de Sousa FCF, Quevedo J, Hyphantis TN, Carvalho AF, Macêdo D
J Affect Disord. 2018 Oct 06;244:67-70
Dal Mas C, Carvalho MS, Marins LA, Yonamine CM, Cordeiro Q, McIntyre RS, Mansur RB, Brietzke E, Hayashi MAF
Nutrition. 2018 Jul 12;58:18-22
Trevizol AP, Brietzke E, Grigolon RB, Subramaniapillai M, McIntyre RS, Mansur RB
Int J Environ Res Public Health. 2018 Sep 21;15(10):
Ho RCM, Chua AC, Tran BX, Choo CC, Husain SF, Vu GT, McIntyre RS, Ho CSH
J Affect Disord. 2018 Sep 12;243:116-120
Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS
Int J Environ Res Public Health. 2018 Sep 12;15(9):
Foo SQ, Tam WW, Ho CS, Tran BX, Nguyen LH, McIntyre RS, Ho RC
Sultan Qaboos Univ Med J. 2018 May;18(2):e167-e172
Alhadi AN, Alarabi MA, Alshomrani AT, Shuqdar RM, Alsuwaidan MT, McIntyre RS
Life Sci. 2018 Sep 04;:
Lu Y, Ho CS, McIntyre RS, Wang W, Ho RC
Harv Rev Psychiatry. 2018 Sep/Oct;26(5):241-249
McIntyre RS, Lee Y, Carmona NE, Subramaniapillai M, Cha DS, Lee J, Lee JH, Alageel A, Rodrigues NB, Park C, Ragguett RM, Rosenblat JE, Almatham F, Pan Z, Rong C, Mansur RB
Neurosci Lett. 2018 Aug 29;:
Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, Zhou H

Pages


 

Head, Mood Disorders Psychopharmacology Unit, UHN
Professor, Departments of Psychiatry and Pharmacology and Toxicology, University of Toronto